Toll-like receptor mediated regulation of effector and memory CD4 T cell response

Toll 样受体介导的效应和记忆 CD4 T 细胞反应的调节

基本信息

  • 批准号:
    8704256
  • 负责人:
  • 金额:
    $ 39.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-15 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs) that recognize a diverse set of Pathogen Associated Molecular Patterns (PAMPs) from different classes of microbes and play an essential role in innate immune defense of the host. In addition, TLRs have been shown to play a critical role in induction of adaptive immune responses. Recognition of PAMPs by TLRs on dendritic cells (DCs) leads to DC maturation, a process that involves enhanced expression of MHC and co-stimulatory molecules as well as migration to the draining lymph nodes to prime naive T cells. TLR activation also leads to production of pro-inflammatory cytokines that contribute to CD4 T cell activation by overcoming Treg mediated suppression. Notably, TLR expression is not limited to DCs. In addition to cells of myeloid origin such as DCs and macrophages, other cells such as neutrophils, epithelial cells, fibroblasts, B lymphocytes and T lymphocytes have been shown to express functional TLRs. Although the outcome of TLR activation in all of these cell types is quite different, their individual contribution to the activation of naive CD4 T cells is not well understood. The overall goals of this study are to characterize TLR dependent mechanisms that control activation of naive CD4 T cells and their differentiation into long lived memory cells. Three specific aims are proposed to study the role of TLRs in controlling adaptive immunity. Aim 1 will characterize the role of different TLR expressing cells in naive CD4 T cell activation. Aim 2 will analyze the contribution of cytokines secreted by DCs, particularly Interleukin-1 and Interleukin-6, to CD4 T cell activation in vivo. Aim 3 proposes to understand the mechanisms by which TLR activation of DCs contributes to generation of CD4 T cell memory. Together these studies will yield novel insights into how recognition of pathogens via TLRs shapes CD4 T cell responses and will lead to better understanding of the mechanisms of innate control of adaptive immune responses in vivo. Furthermore, this work will aid in designing effective vaccine formulations for prophylactic vaccinations.
描述(由申请人提供):Toll样受体(TLR)是模式识别受体(PRR)家族,其识别来自不同类别微生物的多种病原体相关分子模式(PAMP),并在宿主的先天免疫防御中发挥重要作用。此外,TLR已显示在诱导适应性免疫应答中起关键作用。树突状细胞(DC)上TLR对PAMP的识别导致DC成熟,这是一个涉及MHC和共刺激分子表达增强以及迁移至引流淋巴结以引发初始T细胞的过程。TLR活化还导致促炎细胞因子的产生,其通过克服Treg介导的抑制而有助于CD 4 T细胞活化。值得注意的是,TLR表达不限于DC。除了骨髓来源的细胞如DC和巨噬细胞之外,其他细胞如嗜中性粒细胞、上皮细胞、成纤维细胞、B淋巴细胞和T淋巴细胞已显示表达功能性TLR。虽然TLR活化在所有这些细胞类型中的结果是相当不同的,但它们对初始CD 4 T细胞活化的单独贡献还没有很好地理解。本研究的总体目标是表征TLR依赖性机制,其控制幼稚CD 4 T细胞的活化及其分化为长寿记忆细胞。提出了三个具体的目标来研究TLR在控制适应性免疫中的作用。目的1将表征不同TLR表达细胞在初始CD 4 T细胞活化中的作用。目的2分析DC分泌的细胞因子,特别是IL-1和IL-6对体内CD 4 T细胞活化的作用。目的3提出了解TLR激活DC有助于产生CD 4 T细胞记忆的机制。总之,这些研究将产生新的见解如何识别病原体通过TLR形状的CD 4 T细胞反应,并将导致更好地了解先天控制的适应性免疫反应在体内的机制。此外,这项工作将有助于设计有效的疫苗配方,用于预防接种。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment.
  • DOI:
    10.1016/j.immuni.2011.10.013
  • 发表时间:
    2011-12-23
  • 期刊:
  • 影响因子:
    32.4
  • 作者:
    Hu W;Troutman TD;Edukulla R;Pasare C
  • 通讯作者:
    Pasare C
Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.
基于 RNAi 的人类和小鼠 TLR 通路综合筛选可确定信号蛋白使用中的物种特异性偏好。
  • DOI:
    10.1126/scisignal.aab2191
  • 发表时间:
    2016-01-05
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Sun J;Li N;Oh KS;Dutta B;Vayttaden SJ;Lin B;Ebert TS;De Nardo D;Davis J;Bagirzadeh R;Lounsbury NW;Pasare C;Latz E;Hornung V;Fraser ID
  • 通讯作者:
    Fraser ID
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chandrashekhar Pasare其他文献

Chandrashekhar Pasare的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chandrashekhar Pasare', 18)}}的其他基金

ROLE OF BCAP IN REGULATING INFLAMMATION AND ADAPTIVE IMMUNITY
BCAP 在调节炎症和适应性免疫中的作用
  • 批准号:
    9782021
  • 财政年份:
    2018
  • 资助金额:
    $ 39.35万
  • 项目类别:
Innate mechanisms of regulation of memory Th17 cell responses
调节记忆 Th17 细胞反应的先天机制
  • 批准号:
    9246987
  • 财政年份:
    2016
  • 资助金额:
    $ 39.35万
  • 项目类别:
Innate mechanisms of regulation of Th17 responses
Th17 反应调节的先天机制
  • 批准号:
    10388770
  • 财政年份:
    2016
  • 资助金额:
    $ 39.35万
  • 项目类别:
Innate mechanisms of regulation of Th17 responses
Th17 反应调节的先天机制
  • 批准号:
    10545742
  • 财政年份:
    2016
  • 资助金额:
    $ 39.35万
  • 项目类别:
INNATE MECHANISMS OF REGULATION OF MEMORY TH17 CELL RESPONSES
调节记忆 TH17 细胞反应的先天机制
  • 批准号:
    10063467
  • 财政年份:
    2016
  • 资助金额:
    $ 39.35万
  • 项目类别:
Role of BCAP in regulating inflammation and adaptive immunity
BCAP 在调节炎症和适应性免疫中的作用
  • 批准号:
    9206063
  • 财政年份:
    2015
  • 资助金额:
    $ 39.35万
  • 项目类别:
Role of BCAP in regulating inflammation and adaptive immunity
BCAP 在调节炎症和适应性免疫中的作用
  • 批准号:
    8887871
  • 财政年份:
    2015
  • 资助金额:
    $ 39.35万
  • 项目类别:
Role of BCAP in regulating inflammation and adaptive immunity
BCAP 在调节炎症和适应性免疫中的作用
  • 批准号:
    9114459
  • 财政年份:
    2015
  • 资助金额:
    $ 39.35万
  • 项目类别:
Toll-like receptor mediated regulation of effector and memory CD4 T cell response
Toll 样受体介导的效应和记忆 CD4 T 细胞反应的调节
  • 批准号:
    8309820
  • 财政年份:
    2010
  • 资助金额:
    $ 39.35万
  • 项目类别:
Toll-like receptor mediated regulation of effector and memory CD4 T cell response
Toll 样受体介导的效应和记忆 CD4 T 细胞反应的调节
  • 批准号:
    8128607
  • 财政年份:
    2010
  • 资助金额:
    $ 39.35万
  • 项目类别:

相似海外基金

Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
  • 批准号:
    10751133
  • 财政年份:
    2023
  • 资助金额:
    $ 39.35万
  • 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
  • 批准号:
    10696138
  • 财政年份:
    2022
  • 资助金额:
    $ 39.35万
  • 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
  • 批准号:
    10663066
  • 财政年份:
    2022
  • 资助金额:
    $ 39.35万
  • 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
  • 批准号:
    10537159
  • 财政年份:
    2022
  • 资助金额:
    $ 39.35万
  • 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
  • 批准号:
    21K08723
  • 财政年份:
    2021
  • 资助金额:
    $ 39.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
  • 批准号:
    10156950
  • 财政年份:
    2021
  • 资助金额:
    $ 39.35万
  • 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
  • 批准号:
    10631854
  • 财政年份:
    2021
  • 资助金额:
    $ 39.35万
  • 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
  • 批准号:
    10153927
  • 财政年份:
    2021
  • 资助金额:
    $ 39.35万
  • 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
  • 批准号:
    10331830
  • 财政年份:
    2021
  • 资助金额:
    $ 39.35万
  • 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
  • 批准号:
    20K16294
  • 财政年份:
    2020
  • 资助金额:
    $ 39.35万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了